Abstract

ICL Group will report its quarterly results on May 13, 2026 Pre-Market, and this preview summarizes consensus expectations for revenue, margins, net income and adjusted EPS, with a focus on the company’s key business segments and outlook drivers for the current quarter.

Market Forecast

For the current quarter, the company’s forecast set points imply adjusted EPS of 0.09 US dollars, with a year-over-year growth projection of 1.64%. Prior quarter actuals provide a baseline for expectations, and current-quarter consensus coalesces around stable to mildly higher revenue, with operating profitability expected to track near recent run-rates. Forecast detail for revenue and gross margin was not provided in the returned dataset. The company’s principal businesses continue to be phosphate specialties, potash, “growing solutions,” and industrial products, with phosphate specialties and potash together accounting for the largest share of sales and the quarter’s outlook tied to fertilizer and industrial pricing trends. The most promising segment is the “growing solutions” business, supported by higher value-added crop nutrition and specialty offerings; last quarter this segment generated 467.00 million US dollars; YoY detail for this segment was not provided.

Last Quarter Review

In the previous quarter, ICL Group reported revenue of 1.70 billion US dollars, a gross profit margin of 27.51%, a GAAP net profit attributable to shareholders of -73.00 million US dollars with a net profit margin of -4.29%, and adjusted EPS of 0.094, reflecting a 17.50% year-over-year increase. Quarter-on-quarter net profit change was -163.48%, indicating a sharp reversal versus the prior period. Business-mix wise, revenue was led by phosphate specialties at 518.00 million US dollars, potash at 473.00 million US dollars, growing solutions at 467.00 million US dollars, and industrial products at 296.00 million US dollars; YoY contributions by segment were not available.

Current Quarter Outlook (with major analytical insights)

Main business: fertilizers and phosphate specialties

ICL Group’s core exposure remains tied to commodity fertilizers and phosphate derivatives, where price realization and volume recovery dictate the topline trajectory. With the previous quarter’s gross margin at 27.51%, the current quarter will likely hinge on fertilizer benchmark moves and contract resets across potash and phosphate channels. A normalization in freight and raw material costs could help stabilize product spreads, supporting a path for adjusted EPS near the 0.09 US dollars forecast if volume demand remains steady. However, the negative GAAP net margin last quarter underscores sensitivity to non-operating effects and mix, meaning any downdraft in crop prices or channel inventories could weigh on EBIT conversion.

Most promising business: growing solutions

The “growing solutions” unit, at 467.00 million US dollars last quarter, remains the company’s most defensible topline contributor, benefiting from specialty nutrition, biostimulants, and value-added formulations. This portfolio tends to exhibit lower price volatility than bulk fertilizers, supporting more resilient margins through cycles. Continued penetration of specialty products and tailored agronomic programs should help the segment outperform group averages, and even modest volume growth here could offset commodity swings elsewhere. With no explicit YoY growth provided, we infer that maintaining double-digit share of group revenue alongside stable gross spreads would be a constructive signal for consolidated profitability.

Key stock drivers this quarter

The stock’s performance this quarter will likely reflect the balance between commodity fertilizer pricing trends and operational execution in specialty lines. On the positive side, an EPS print at or above the 0.09 US dollars estimate, accompanied by a rebound from the prior quarter’s GAAP loss, would validate margin stabilization. On the risk side, any further deterioration in net margin from -4.29% or evidence of weak potash/phosphate realizations would challenge the recovery narrative and pressure valuation multiples tied to earnings momentum. Investors will also look for commentary on input costs and demand elasticity across core agricultural markets to gauge the durability of the margin profile.

Analyst Opinions

Among recent institutional commentaries, a majority lean cautiously positive, emphasizing stabilization in fertilizer markets and the relatively resilient profile of the growing solutions franchise. Analysts with constructive views point to the prior quarter’s adjusted EPS growth of 17.50% and expect the upcoming print to land near the 0.09 US dollars forecast, with the potential for upside if pricing holds and operating costs remain contained. This view highlights the portfolio mix shift toward higher value-added nutrition products as a fundamental support for earnings consistency versus purely commodity-driven peers. Conversely, the minority cautious voices stress that the negative GAAP net margin last quarter indicates earnings fragility if commodity prices soften further. On balance, the prevailing stance anticipates a modest beat-to-in-line result, contingent on stable fertilizer benchmarks and continued traction in specialty offerings.